In vivo the immunological effects of Fasciola gigantica worms homogenate mixed with saponin on mice infected with Schistosoma mansoni

Journal of Medical Sciences

Volumn 7, Issue 5, 2007, Pages 724-731

  Maghraby, S A ^a   Shker, Kamel H ^b   Zahran, H G ^a   El Sherbiny, Mahmoud ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

Electrophoretic scanning; Enzyme linked immunosorbent assay; Fasciola gigantica; Immunoprophylactic; Saponin; Schistosoma mansoni

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARASITE ANTIGEN; SAPONIN; TISSUE EXTRACT; UNCLASSIFIED DRUG; WORM EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CERCARIA; CONTROLLED STUDY; DRUG ACTIVITY; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FASCIOLA GIGANTICA; FEMALE; HOMOGENATE; IMMERSION; IMMUNIZATION; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; IN VIVO STUDY; LYMPHOCYTE; MOUSE; NONHUMAN; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPLEEN CELL; STAINING; WORM INFECTION;

EID: 34250849728     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2007.724.731     Document Type: Article

References (28)

1. Bergquist, N.R., B.F. Hall S. and James, 1994. Schistosomiasis vaccine development: Translating basic research into practical results. Immunologist, 2: 131-134.
2. Bergquist, N.R., 2002. Schistosomiasis. From risk assessment to control. Trends Parasitol., 18: 309-314.
3. Capron, A., J.P. Dessaint, M. Capron and R.J. Pierce, 1992. Vaccine strategies against schistosomiasis. Immunology, 184: 282-294.
4. Chrambach, A., 1985. The Practice of Quantitative Gel Electrophoresis. VCH press, Weiheim, pp: 23-27.
5. Cunha, C.W., T.C. MeGuire, L.S. Kappmeyer, S.A. Hines, A.M. Lopez, O.A. Dellagostin and D.P. Knowles, 2006. Development of specific immunoglobulin Ga (IgGa) and IgGb antibodies correlates with control of parasitemia in Babesia equi infection. Clin. Vaccine Immunol., 13: 297-300.
6. Doenhoff, M. and P.L. Mattoccia, 2006. Praziquantel for the treatment of schistosomiasis: Its use for control in areas with endemic disease and prospects for drug resistance. Exp. Rev. Ant. Infect. Ther., 4: 199-210.
7. Duvall, R. and W.B. De Witt, 1961. An improved perfusion technique for recovering adult Schistosomes from laboratory animals. Am. J. Trop. Med. Hyg., 32: 61.
8. Fallon, G., J.V. Hamilton and M. Doenhoff, 1995. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: Role of host antibody. Parasitology, 111: S9.
9. Farrag, E.K., A.M. Soliman, I. Nabih, M. El Sherbiny and A.M. Ibrahim, 2005. Purification and characterization of antigens extracted from Biomphalaria alexandrina and Lymnaea cailliaudi and their potential use as antischistosomal vaccine. J. Egypt. Ger. Soc. Zool., 47D: 105-131.
10. Fonseca, C.T., B. Cunha-Neto, J. Kalil A.R. Jesus de and R. Correa-Oliveria et al., 2004. Identification of immunodominant epitopes of Schistosoma mansoni vaccine candidate antigens using human T cells. Mem. Inst. Oswaldo Cruz, Rio de Janeriro., 99: 63-66..
11. Harder, A., 2002. Chemotherapeutic approaches to schistosomes: Current knowledge and outlook. Parasitol. Res., 88: 395-397.
12. Hillyer, G.V., R.P. Pelley A. del Liano de Diaz, 1979. Solubilization of antigens of Fasciola hepatica which react with antibodies to Schistosoma mansoni. J. Parasitol., 65: 55-60.
13. Hillyer, G.V., 1995. Comparison of purified 12 KDa and recombinant 15 KDa Fasciola hepatica antigens related to a Schistosoma mansoni fatty acid binding protein. Memorias Instituto Oswaldo Cruz, 90: 249-253.
14. Hillyer, G.V., 2005. Fasciola antigens as vaccines against fascioliasis and schistosomiasis. J. Helminthol., 79: 241-7.
15. Julie Levane-Garcia A., A. Renato, B. Mortara, A. Sergio Verjovski-Almeida and A. Ricardo DeMarca, 2007. characterization of Schistasana mansoni ATPDase2 gene, a novel apyrase family member. Biochem. Biophys. Res. Commun., 352: 384-389.
16. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature, 221: 680-685.
17. Maghraby, AS., 1989. Effect of bilharcid on the immune system of healthy and schistosoma mansoni infected mice: M.S. Thesis, Faculty of Science, Cairo University, Egypt.
18. Oliveira-Freitas, C.P., G.P. Cassas, F.N. Borja-Cabrera, D. Santos Nico and L.O. Souza et al., 2006. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis. Vaccine, 24: 3909-3920.
19. Oliver, L. and Stirewalt, 1952. An effective method for the exposure of mice to cercariae of Schistosoms msnsoni. J. Parasitol., 38: 19-24.
20. Pelley, R.P. and G.V. Hillyer, 1978. Demonstration of a common antigen between Schistosoma mansoni and Fasciola hepatica. Am. J. Trop. Med. Hyg., 27: 1192-1194.
21. Raina, O.K., S.C. Yadav, D. Sriveny and S.C. Gupta, 2006. Immunodiagnosis of bubaline fasciolasis with Fasciola gigantica Cathepsin-L and recombinant cathepsin L 1-D preteases. Acta Trop., 98: 145-151.
22. Rashida, B., E. Hala and F. Alan, 2005. Efficacy of Myrrh in the treatment of human schistescniasis manson. Am. J. Trop. Med. Hyg., 73: 365-367.
23. Raso, G., E. N'Goran, A. Toty, A. Luginbuhl, C. Adjoua, N.T. Tian-Bi, I.I. Bogoch, P. Vounatsou, M. Tanner, and J. Utzinger, 2004. Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Cote d'Ivoire. Trans. R. Soc. Trop. Med. Hyg., 98: 18-27.
24. Ronald T., S. Chapman and L. Hall, 1983. Statistics in Research development. 264-300. The CHAUCER press LTD. Bungay, SUFFOLK, N.Y. and London.
25. Schetters, T.J. Kleuskens, S. Randazzo, K. Hadj-Kaddour, S. Delbecq, E. Precigout and A. Gorenflot, 2006. Hydrophobic moeties in recombinant proteins are crucial to generate efficient saponin-based vaccine against Apicomplex an Babesia divergens. Vaccine, 24: 613-621.
26. Suda, I., S. Furuta, Y. Nishiba, O. Yamakawa, K. Mastsugano and K. Sugita, 1997. Sweet Potato Res. Front (KNAES, Japan) 4: 3. es. J. Parasitol., 87: 292-299.
27. Syang, Z., A. Chen, H. Sun, Y. Ye and W. Fang, 2006. Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice. Vaccine, 25: 161-169.
28. Tolba, M.B., I. Nabih, A. Attallah, A. Soliman and M. El-Sherbiny, 1995. Effects of irradiation and chemical treatment on Biomphalaria alexandrina antigens. J. Union. Arab. Biol., Cairo. Egypt, 3: 29-40.